iSERA Lifesciences Limited

As of June 30, 2026, iSERA Lifesciences Limited carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at 1.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, iSERA Lifesciences Limited has 8.41M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 80.17 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.09B versus a market cap of 1.09B, with the gap driven by net debt and cash on the balance sheet.

Over the twelve months ended June 30, 2026, iSERA Lifesciences Limited recorded 770,000.00 in income tax expense. That works out to an effective tax rate of 493.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 156,000.00, leaving -614,000.00 in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 21, 2026, iSERA Lifesciences Limited's stock has gained approximately 1771.26% over the past 52 weeks. The 50-day moving average sits at 144.04, while the 200-day moving average is 75.48.

Over the twelve months ended June 30, 2026, iSERA Lifesciences Limited generated 13.55M in revenue and converted that into -614,000.00 in net income, yielding earnings per share of -0.10. EBITDA reached -491,000.00, while operating income came in at -491,000.00.

Over the twelve months ended June 30, 2026, iSERA Lifesciences Limited posted a gross margin of 94.82, reflecting its pricing power and cost economics. The operating margin of -3.62 and net profit margin of -4.53 provide insight into operational efficiency.

iSERA Lifesciences Limited's most recent stock split took place on March 22, 2024 with a 1000:3 split ratio.